Regenerative Medicine Products Market to Reach $2.85 billion by 2010, According to New Report by Global Industry Analysts, Inc.
Regenerative medicine is touted as the next-generation technology to revolutionize the medical system of future. The market for regenerative medicine in bone and joint applications is primarily driven by ageing baby boomer population and escalating incidence of osteoporosis, arthritis, and other bone and joint traumas. By the year 2010, global market (comprising United States, Japan, and Europe) for regenerative medicine products for bone and joint applications is projected to reach $2.85 billion.
San Jose, CA (PRWEB) April 10, 2008 -- Science of regeneration offers huge opportunities for the betterment of mankind. Regenerative medicine offers therapeutic opportunities where there are presently no treatments. The regenerative medicine industry is in nascent stages in terms of commercial applications. To date, most of the advances made in regenerative medicine are confined to bone and joint applications, and to an extent regeneration of blood. Even in bone and joint applications the advances are limited to invitro development. Huge opportunity for regenerative medicine exists in invivo development. It would not be long before regenerative therapies for chronic conditions such as diabetes are realized.
United States dominates the global market for regenerative medicine for bone and joint, accounting for about 3/4th of the market, as stated in a recent report published by Global Industry Analysts, Inc. Japan and Europe are other important markets for regenerative medicine products in bone and joint applications. Regenerative medicine market in Europe is projected to witness high growth - a CAGR of 17% over the period 2003-2010.
Companies promoting development of the technology based on sound research, would be able to leverage growth opportunities in the industry. The increasing trend of alliances between research laboratories and commercially successful healthcare companies would also enable the industry to achieve faster growth. Major players in the marketplace include BioVest International, Inc., Curis, Inc., Cytori Therapeutics, Inc., DeveloGen AG, Forticell Bioscience, Inc., Geron Corporation, Human Genome Sciences, Inc., IsoTis, Inc., Kiadis Pharma B.V., LifeCell Corporation, Osiris Therapeutics, Inc., Tepha Inc., and TiGenix N.V.
"Regenerative Medicine: A Global Strategic Business Report", published by Global Industry Analysts, Inc., covers major market dynamics, growth drivers, restraints, trends, issues, and competition pertaining to the market. The report enumerates recent developments, mergers, acquisitions and other strategic industry activities. Analysis is presented for major geographic markets such as US, Japan, and Europe. Analytics are provided for the period 2003 through 2010.
For more details about this research report, please visit http://www.strategyr.com/Regenerative_Medicine_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site http://www.strategyR.com/
###
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1DcmFzLUNvdXAtQ3Jhcy1TdW1tLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
